Gilenya (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Gilenya drug offered from Novartis Pharmaceuticals Corporation. This Sphingosine 1-Phosphate Receptor Modulators [MoA],Sphingosine 1-phosphate Receptor Modulator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | Fingolimod hcl |
| SUBSTANCE NAME: | FINGOLIMOD HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Sphingosine 1-Phosphate Receptor Modulators [MoA],Sphingosine 1-phosphate Receptor Modulator [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-09-21 |
| END MARKETING DATE: | 0000-00-00 |
Gilenya HUMAN PRESCRIPTION DRUG Details:
| Item Description | Gilenya from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2010-09-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0607_33fab7b6-43cc-4784-9ac2-8dadafc0ee59 |
| PRODUCT NDC: | 0078-0607 |
| APPLICATION NUMBER: | NDA022527 |
Other FINGOLIMOD HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
